FDA Inspection 1249042 — Cliantha Research Limited

Cliantha Research Limited — FEI 3017682080

The FDA completed an inspection of Cliantha Research Limited on May 31, 2024 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 31, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ahmedabad (India)

Additional Details

Bioanalytical BA/BE